APA (7th ed.) Citation

J, G., A, C., Y, S., J, N., BB, B., RJ, S., . . . BA, M. (2008). Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck. Cancer, 113(1), 186. https://doi.org/10.1002/cncr.23545

Chicago Style (17th ed.) Citation

J, Gilbert, et al. "Phase II Trial of Irinotecan Plus Cisplatin in Patients with Recurrent or Metastatic Squamous Carcinoma of the Head and Neck." Cancer 113, no. 1 (2008): 186. https://doi.org/10.1002/cncr.23545.

MLA (9th ed.) Citation

J, Gilbert, et al. "Phase II Trial of Irinotecan Plus Cisplatin in Patients with Recurrent or Metastatic Squamous Carcinoma of the Head and Neck." Cancer, vol. 113, no. 1, 2008, p. 186, https://doi.org/10.1002/cncr.23545.